| AIP | Atherogenic index of plasma |
| BMI | Body mass index |
| CAD | Coronary artery disease |
| CRI-I | Castelli risk index I |
| CRI-II | Castelli risk index II |
| CV | Cardiovascular |
| EC | Endothelial cell |
| HDL | High-density lipoprotein |
| hsCRP | High-sensitivity C-reactive protein |
| IDL | Intermediate-density lipoprotein |
| IFN-γ | Interferon gamma |
| IL | Interleukin |
| IR | Insulin resistance |
| LDL | Low-density lipoprotein |
| LOX-1 | Lectin-like oxidized low-density lipoprotein receptor-1 |
| MACEs | Major adverse cardiac events |
| MetS | Metabolic syndrome |
| MI | Myocardial infarction |
| NO | Nitric oxide |
| Non-HDL | Non-HDL cholesterol |
| Ox-LDL | Oxidized low-density lipoprotein |
| RCVEs | Recurrent cardiovascular events |
| T2D | Type 2 diabetes |
| TC | Total cholesterol |
| TG | Triglycerides |
| TNF-α | Tumor necrosis factor-alpha |
| TRL-C | Triglyceride-rich lipoprotein cholesterol |
| VLDL | Very low density lipoprotein |
| VSMC | Vascular smooth muscle cells |